SNY サノフィ

銘柄追加

50.030
+0.800+1.63%

終値 05/01 16:00 ET

49.000
-1.030-2.06%

市場前 04:50 ET

1,248.97億時価総額25.87直近PER

サノフィについて

サノフィは医薬品とワクチンの研究、開発、製造、販売を展開するフランスの製薬会社。糖尿病、がん、血栓症、循環器疾患、中枢神経系疾患、内科系疾患の治療領域で医療用医薬品を提供。主要製品は、ヒトインスリン製剤｢ランタス｣、｢Apidra｣、抗がん剤｢タキソテール｣、結腸直腸がん治療薬｢Eloxatine｣、抗血小板剤｢プラビックス｣など。

基本情報

銘柄コードSNY

会社名サノフィ

設立日1994

CEOMr. Paul Hudson

市場ナスダック

従業員87994

証券の種類DR

ADS率2.0 : 1.0

会計年度末12-31

住所46, avenue de la Grande Armée

都市Paris

省Ile-de-France

国名フランス

郵便番号75017

電話番号33-1-53-77-40-00

Webサイトhttp://www.sanofi.com

経営陣

名称
役職
年給

Paul Hudson
Director and Chief Executive Officer
553.40万

Jean-Baptiste Chasseloup De Chatillon
Executive Vice President and Chief Financial Officer
--

Natalie Bickford
Executive Vice President and Chief People Officer
--

Emmanuel Frenehard
Executive Vice President and Chief Digital Officer
--

Roy Papatheodorou
Executive Vice President and General Counsel
--

Olivier Charmeil
Executive Vice President, General Medicines
--

Thomas Triomphe
Executive Vice President, Vaccines
--

Madeleine Roach
Executive Vice President, Business Operations
--

Houman Ashrafian
Executive Vice President and Head of Research and Development
--

Brian Foard
Executive Vice President, Specialty Care
--

Brendan O'Callaghan
Executive Vice President, Global Manufacturing & Supply
--

Julie Van Ongevalle
Executive Vice President, Consumer Healthcare
--

Frederic Oudea
Chairman of the Board
--

Barbara Lavernos
Director
4.75万

Wolfgang Laux
Director
4.20万

Christophe Babule
Director
12.90万

Yann Tran
Director
4.20万

Fabienne Lecorvaisier
Independent Director
14.55万

Thomas Sudhof
Independent Director
14.55万

Gilles Schnepp
Independent Director
15.10万

Rachel Duan
Independent Director
11.80万

Patrick Kron
Independent Director
14.83万

Lise Kingo
Independent Director
9.88万

Carole Ferrand
Independent Director
--

Emile Voest
Independent Director
--

Dr. Antoine Yver, M.D.,M.Sc.
Independent Director
--

Diane Souza
Independent Director
16.75万

分析

アナリスト評価

データなし

目標株価